Market forces rained on the parade of CureVac N.V. ( NASDAQ:CVAC ) shareholders today, when the analysts downgraded...
CureVac ( NASDAQ:CVAC ) Full Year 2023 Results Key Financial Results Revenue: €53.8m (down 20% from FY 2022). Net loss...
Key Insights The considerable ownership by private equity firms in CureVac indicates that they collectively have a...